IQV Iqvia Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSE: IQV

Price (delayed)

$186

Market cap

$31.04B

P/E Ratio

22.88

Dividend/share

N/A

EPS

$8.13

Enterprise value

$45.16B

?
Relative Growth: Rel. Growth: 74
Relative Strength: Rel. Strength: 49
Relative Valuation: Rel. Valuation: 64
Relative Profitability: Rel. Profitability: 68

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development ...

Highlights
The price to earnings (P/E) is 37% lower than the 5-year quarterly average of 35.5 and 9% lower than the last 4 quarters average of 24.5
IQV's EPS is up by 10% year-on-year and by 2.8% since the previous quarter
The equity has contracted by 4.3% from the previous quarter but it has grown by 4.1% YoY
Iqvia Holdings's debt has increased by 11% YoY
The quick ratio has decreased by 10% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://ir.iqvia.com/

Key stats

What are the main financial stats of IQV

IQV stock price

How has the Iqvia Holdings stock price performed over time
Intraday
2.17%
1 week
2.71%
1 month
15.57%
1 year
25.76%
YTD
-17.48%
QTD
9.07%

Financial performance

How have Iqvia Holdings's revenue and profit performed over time
Revenue
$16.63B
Gross profit
$5.49B
Operating income
$2.2B
Net income
$1.39B
Gross margin
33%
Net margin
8.3%
IQV's revenue is up by 7% YoY
Iqvia Holdings's operating margin has decreased by 6% YoY
The gross margin has decreased by 4.9% YoY
Iqvia Holdings's net income has increased by 3.8% YoY

Price vs fundamentals

How does IQV's price correlate with its fundamentals

Growth

What is Iqvia Holdings's growth rate over time

Valuation

What is Iqvia Holdings stock price valuation
IQV P/E details
P/E
22.88
P/B
5.07
P/S
1.88
EV/EBIT
18.89
EV/EBITDA
12.69
EV/Sales
2.72
The price to earnings (P/E) is 37% lower than the 5-year quarterly average of 35.5 and 9% lower than the last 4 quarters average of 24.5
IQV's EPS is up by 10% year-on-year and by 2.8% since the previous quarter
The stock's price to book (P/B) is 24% less than its 5-year quarterly average of 6.5 and 2.5% less than its last 4 quarters average of 5.1
The equity has contracted by 4.3% from the previous quarter but it has grown by 4.1% YoY
The stock's price to sales (P/S) is 32% less than its 5-year quarterly average of 2.7 and 8% less than its last 4 quarters average of 2.0
IQV's revenue is up by 7% YoY

Efficiency

How efficient is Iqvia Holdings business performance
The ROE has increased by 9% YoY
IQV's return on assets is down by 4.1% year-on-year
The company's return on invested capital fell by 3.9% YoY
IQV's return on sales is down by 3.4% year-on-year

Dividends

What is IQV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IQV.

Financial health

How did Iqvia Holdings financials performed over time
The total assets is 27% greater than the total liabilities
The quick ratio has decreased by 10% YoY
The total assets is up by 9% year-on-year
Iqvia Holdings's debt is 158% more than its equity
Iqvia Holdings's debt has increased by 11% YoY
The debt to equity has increased by 6% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.